Syros Pharmaceuticals (SYRS) Q3 2023 Earnings

Nov 14Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-1.43
-1.01
-0.59
-0.17

Details

Expected EPS
-1.14
Actual EPS
-1.43
Surprise EPS
-0.29
Surprise Percent
-25.44%

Description

⁨Syros Pharmaceuticals⁩ (⁦SYRS⁩) has reported earnings of ⁦-1.43⁩ per share for ⁦Q3 2023⁩.

0 Comments

Share your thoughts